They aim to transform output and labor requirements for CGT manufacturing using automated robotics manufacturing capabilities ...

Fareva has opened a new GMP Pilot Unit at its Pau site to produce liquid and lyophilized injectable forms. With its new ...

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.

This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

The collaboration aims to advance the discovery and development of novel oral candidates.